SANDU PHARMA Fact Sheet, SANDU PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA Fact Sheet    (SNPH)


Don't Miss: Introducing Equitymaster's Latest Research Project


Here is the latest financial fact sheet of SANDU PHARMA. For more details, see the SANDU PHARMA quarterly results and SANDU PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

SANDU PHARMA Price History

Price Rs 51.1
Mkt Cap Rs m 361
Vol '000 3.9
P/E X 23.1
P/CF X 28.4
EPS (TTM) Rs 2.2
% ch % -1.9
No. of shares m 7.08
% ch week % -6.5
% ch 1-mth % 1.7
% ch 12-mth % 113.2
52 week H/L Rs 62.9/22.8
(As on Sep 24, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SANDU PHARMA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
SANDU PHARMA EQUITY SHARE DATA
High Rs5045424027 
Low Rs2024231810 
Sales per share (Unadj.) Rs57.059.369.069.868.3 
Earnings per share (Unadj.) Rs0.8-0.60.80.91.0 
Diluted earnings per shareRs0.8-0.60.80.91.0 
Cash flow per share (Unadj.) Rs1.70.61.61.81.8 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs26.438.739.740.741.3 
Adj. book value per shareRs26.438.739.740.741.3 
Shares outstanding (eoy) m7.087.087.087.087.08 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.60.60.50.40.3 
Avg P/E ratio x45.9-55.140.730.918.4 
P/CF ratio (eoy) x20.157.919.615.910.4 
Price / Book Value ratio x1.30.90.80.70.5 
Dividend payout %00000 
Avg Mkt Cap Rs m247245229207133 
No. of employees `000NANANANANA 
Total wages/salary Rs m4554596569 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
SANDU PHARMA INCOME DATA
Net Sales Rs m403420489494484 
Other income Rs m15165 
Total revenues Rs m405425490500488 
Gross profit Rs m2919252115 
Depreciation Rs m79666 
Interest Rs m161512104 
Profit before tax Rs m718109 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m15232 
Profit after tax Rs m5-4677 
Gross profit margin %7.14.65.04.23.0 
Effective tax rate %20.8938.825.734.221.6 
Net profit margin %1.3-1.11.11.41.5 
SANDU PHARMA BALANCE SHEET DATA
Current assets Rs m329280208201224 
Current liabilities Rs m210181154139113 
Net working cap to sales %29.323.411.212.622.9 
Current ratio x1.61.51.41.42.0 
Inventory Days Days79464818 
Debtors Days Days6555503535 
Net fixed assets Rs m85185237236190 
Share capital Rs m7171717171 
"Free" reserves Rs m116203210217222 
Net worth Rs m187274281288292 
Long term debt Rs m81220 
Total assets Rs m414464445436414 
Interest coverage x1.41.01.62.03.1 
Debt to equity ratio x00000 
Sales to assets ratio x1.00.91.11.11.2 
Return on assets %5.32.34.03.92.8 
Return on equity %2.9-1.62.02.32.5 
Return on capital %11.95.67.07.04.6 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
SANDU PHARMA CASH FLOW
From Operations Rs m -14 49 12 37 62 
From Investments Rs m 0 -6 -6 -1 -1 
From Financial Activity Rs m -21 -23 -19 -43 -54 
Net Cashflow Rs m -34 20 -13 -6 8 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 45.0%
Institution 0.0%
Non-Institution 55.0%
Total 100.0%
Free Float 55.0%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Plot No 25 26 29 & 30, Pilerne Industrial Estate , Marra , Bardez - 403511
E-MAIL info@sandu.in WEB www.sandu.in
TEL +91-832-2407473/2407474/2841044 FAX +91-832-2407008
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, L B S Marg, Vikhroli (West)
YEAR OF INC: 1985 BSE CODE: 524703 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   NARAYANA HRUDAYALAYA  LAURUS LABS   FERMENTA BIOTECH  PHARMAIDS PH  KWALITY PHARMA  

Compare SANDU PHARMA With:   NARAYANA HRUDAYALAYA  LAURUS LABS   FERMENTA BIOTECH  PHARMAIDS PH  KWALITY PHARMA  




Today's Market

Sensex Ends Above 60,000-Mark, Nifty Tops 17,850; Asian Paints & Eicher Motors Climb 3%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

A Rare Buying Opportunity in an Exciting Stock (Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield (Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

A Great Time to Buy ITC (Profit Hunter)

Sep 17, 2021

Is the worst over for the stock of ITC?

This Indian Company is Tapping into the Huge Autonomous Driving Opportunity (Views On News)

Sep 14, 2021

Despite many challenges, Indian companies and startups have not shied away from entering this space.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SANDU PHARMA

  • Track your investment in SANDU PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SANDU PHARMA

SANDU PHARMA 8-QTR ANALYSIS

COMPARE SANDU PHARMA WITH

MARKET STATS